These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The mesocortical dopamine projection to anterior cingulate cortex plays no role in guiding effort-related decisions. Walton ME; Croxson PL; Rushworth MF; Bannerman DM Behav Neurosci; 2005 Feb; 119(1):323-8. PubMed ID: 15727537 [TBL] [Abstract][Full Text] [Related]
45. The reinforcing and rate effects of intracranial dopamine administration. Dworkin SI; Goeders NE; Smith JE NIDA Res Monogr; 1986; 67():242-8. PubMed ID: 3092072 [No Abstract] [Full Text] [Related]
46. Electrophysiological basis of the reinforcing effects of cocaine. White FJ Behav Pharmacol; 1990; 1(4):303-315. PubMed ID: 11175415 [TBL] [Abstract][Full Text] [Related]
47. Active immunization with cocaine-protein conjugate attenuates cocaine effects. Ettinger RH; Ettinger WF; Harless WE Pharmacol Biochem Behav; 1997 Sep; 58(1):215-20. PubMed ID: 9264094 [TBL] [Abstract][Full Text] [Related]
48. Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies. Regnier SD; Lile JA; Rush CR; Stoops WW J Exp Anal Behav; 2022 May; 117(3):420-441. PubMed ID: 35229294 [TBL] [Abstract][Full Text] [Related]
49. Cocaine-induced metabolic activation in cortico-limbic circuitry is increased after exposure to the histone deacetylase inhibitor, sodium butyrate. Febo M; Akbarian S; Schroeder FA; Ferris CF Neurosci Lett; 2009 Nov; 465(3):267-71. PubMed ID: 19638299 [TBL] [Abstract][Full Text] [Related]
50. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. Richardson NR; Roberts DC J Neurosci Methods; 1996 May; 66(1):1-11. PubMed ID: 8794935 [TBL] [Abstract][Full Text] [Related]
51. Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors. Rothman RB; Gendron T; Hitzig P J Subst Abuse Treat; 1994; 11(3):273-5. PubMed ID: 8072057 [No Abstract] [Full Text] [Related]
52. The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction. Maharajan P; Maharajan V; Ravagnan G; Paino G Prog Neurobiol; 2001 Jun; 64(3):269-76. PubMed ID: 11240309 [TBL] [Abstract][Full Text] [Related]
53. Effects of withheld reinforcement on timing behavior of rats with limbic lesions. Caplan M J Comp Physiol Psychol; 1970 Apr; 71(1):119-35. PubMed ID: 5452099 [No Abstract] [Full Text] [Related]
54. Environmental regulation of the development of mesolimbic dopamine systems: a neurobiological mechanism for vulnerability to drug abuse? Meaney MJ; Brake W; Gratton A Psychoneuroendocrinology; 2002; 27(1-2):127-38. PubMed ID: 11750774 [TBL] [Abstract][Full Text] [Related]
55. The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Fibiger HC Can J Neurol Sci; 1984 Feb; 11(1 Suppl):105-7. PubMed ID: 6324981 [TBL] [Abstract][Full Text] [Related]
57. Respiratory effects of stimulation of the limbic cortex in rats and their modulation with serotonin. Vedyasova OA Bull Exp Biol Med; 2005 Sep; 140(3):265-7. PubMed ID: 16307031 [TBL] [Abstract][Full Text] [Related]
58. [Overview of the progress in drug dependence studies--mainly focussing on psychic dependence]. Yanagita T Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):97-107. PubMed ID: 1427500 [TBL] [Abstract][Full Text] [Related]
59. [Participation of dopamine in motivation]. Prado-Alcala RA Bol Estud Med Biol; 1986; 34(1-4):57-63. PubMed ID: 3828036 [No Abstract] [Full Text] [Related]
60. The role of the limbic system in pain interpretation. Foltz EL Ariz Med; 1969 Dec; 26(12):1033-40. PubMed ID: 4905845 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]